For the Media
Dr. Anne Mctiernan is a member of Fred Hutch's Public Health Sciences Division. Her research is focused on identifying ways to prevent new or recurrent cancer with a particular focus on weight control, physical activity, and chemoprevention. Dr. McTiernan is an elected Fellow in the American College of Sports Medicine, the Obesity Society, and the American College of Epidemiology. She was a co-Investigator in the Women's Health Initiative (WHI), and directed clinical outcomes efforts at the WHI Clinical Coordinating Center.
Overview of Anne McTiernan's Research
Dr. McTiernan has led several NCI-funded grants to test weight loss and exercise effects on biomarkers of breast cancer, colon cancer, and other cancers and diseases.
Anne McTiernan – Brief Curriculum Vitae
Appointments, affiliations and researcher interests.
Featured Research Profile
As a cancer prevention researcher and pragmatist, Anne McTiernan has no illusions about most folks' commitment to exercise. She understands that people want to know exactly what they have to do — and how little they need to do — to reap healthy rewards.
Public Health Sciences Division
Using large populations as their "laboratory," our public-health researchers look for links between cancer and its possible triggers, from diet and lifestyle to environmental and genetic factors. Identifying such cancer causes can lead to better cancer-detection methods and new ways to help people adopt healthier lifestyles to minimize or avoid their risk of getting the disease in the first place.
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch’s pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation’s first cancer prevention research program, as well as the clinical coordinating center of the Women’s Health Initiative and the international headquarters of the HIV Vaccine Trials Network.